This bibliography contains selected articles identified in the preliminary literature review conducted by the Institute and covering the biochemistry of glycolysis, possible GMI control points, and the biophysical effects of radiowaves.

Adams S (2001) Imaging fluorescent probes in living cells, tissues and animals. Proc. Intl. Soc. Mag. Reason. Med. 9: 1-1

Ardizzoni A, Tiseo M, Boni L, et al. (2006) CISA (cisplatin vs. carboplatin) meta-analysis: an individual patient data meta-analysis comparing cisplatin versus carboplatin-based chemotherapy in first-line treatment of advance non-small cell lung cancer (NSCLC). J Clinical Oncology. 24: –

Atsumi T, Chesney J, Metz C, et al. (2002) High expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (ipfk-2; pfkfb3) in human cancers. . : –

Ben-Yosef R, Kapp D (1995) Direct clinical comparison of ultrasound and radiative electromagnetic hyperthermia applicators in the same tumours. Int J Hyperthermia. 11: 1-10

Ben-Yosef R, Kapp D (1992) Persistent and/or late complications of combined radiation therapy and hyperthermia. Int J Hyperthermia. 8: 733-745

Bergh J, Jonsson P, Glimelius B, et al. (2001) A systematic overview of chemotherapy effects in breast cancer. Acta Oncologica. 40: 253-281

Berghmans T, Paesmans M, Meert A, et al. (2006) Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: results of a meta-analysis of the literature.. Lung Cancer. 51: 261-262

Birim O, Kappetein P, Goorden T, et al. (2005) Proper treatment selection may improve survival in patients with clinical early-stage nonsmall cell lung cancer. Ann Thorac Surg. 80: 1021-1026

Birring S (2004) Adjuvant chemotherapy and survival in completely resected non-small cell lung cancer. Thorax. 59: 341-

Black D, Heynick L (2003) Radiofrequency (RF) effects on blood cells, cardiac, endocrine, and immunological functions. Bioelectomagnetics Supplement . 6: S187-S195

Blackhall F, Shepherd F, Albain K (2005) Improving survival and reducing toxicity with chemotherapy in advanced non-small cell lung cancer: a realistic goal?. Tret Respir Med. 4: 71-84

Bozoky G, Ruby E, Goher I, et al. (2005) The effect of chemo-radiotherapy on the remission and survival in patients with limited stage small cell lung cancer. Orv Hetil. 146: 1433-1438

Brenner H, Arndt V (2005) Long-term survival rates of patients with prostate cancer in the prostate-specific antigen screening era: population-based estimates for the year 2000 by period analysis. J Clinical Oncology. 23: 441-447

Bria E, Gralla R, Raftopoulos H, et al. (2005) Does adjuvant chemotherapy improve survival in non small cell lung cancer (NSCLC)? A pooled-analysis of 6494 patients in 12 studies, examining survival and magnitude of benefit. J Clinical Oncology. 23: –

Brusselmans K, de Schrijver E, Verhoeven G, et al (2005) RNA Interference-mediated silencing of the acetyl-cola-carboxylase-gene induces growth inhibition and apoptosis of prostate cancer cells. Cancer Research. 65: 6719-6725

Burckhardt C, Anderson K (2003) The quality of life scale (QOLS): reliability, validity, and utilization. Health and Quality of Life Outcomes. 1: –

Byrne B, Crawford J, Gay G, et al. (2004) Trends in chemotherapy use and survival for patients with metastatic non-small cell lung cancer. J Clinical Oncology. 22: –

Camilleri-Brennan J, Steele R (2001) Prospective analysis of quality of life and survival following mesorectal excision for rectal cancer. British J Surgery. 88: 1617-

Caraceni A, Brunelli C, Martini C, et al. (2005) Cancer pain assessment in clinical trials. A review of the literature (1999-2002). J Pain and Symptom Management. 29: 507-519

Caraceni A, Cherny N, Fainsinger R, et al. (2002) Pain management tools and methods in clinical research in palliative care: recommendations of an expert working group of the european association of palliative care. J Pain and Symptom Management. 23: 239-255

Chan A, Mao A, Wu T, et al. (2005) Meta-analysis comparing carboplatin and cisplatin-based chemotherapy in advanced non-small cell lung cancer. J Clinical Oncology. 23: –

Chan Y, Meng M, Wu K, et al (2005) Experimental study of radiation efficiency from an ingested source inside a human body model. Conference. : –

Chevalier T, Scagliotti G, Natale R, et al. (2005) Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes. Lung Cancer. 47: 69-80

Collette L, van Andel G, Bottomley A, et al. (2001) Is baseline quality of life useful for predicting survival with hormone-refractory prostate cancer? A pooled analysis of three studies of the European organisation for research and treatment cancer genitourinary group. J Clinical Oncology. 22: 3877-3885

Cuezva J, Krajewska M, Lopez K, et al. (2002) The bioevergetic signature of cancer; a marker of tumour progression. Cancer Research. 62: 6674-681

D’Addario G, Strasser F, Ribi K, et al. (2006) Quality of life (QoL) in SAKK 19/03: A multicenter phase II study of first-line gefitinib followed by chemotherapy in patients with advanced non-small cell lung cancer (NSCLC). Swiss group for clinical cancer reserch (SAKK).. J Clinical Oncology. 24: –

Dooms C, Pat K, Vansteenkiste J (2006) The effect of chemotherapy on symptom control and quality of life in patients with advanced non-small cell lung cancer. Expert Review of Anticancer Therapy. 6: 531-544

DuBois J, Hay M, Borduret G (1990) Superficial microwave-induced hyperthermia in the treatment of chest wall recurrences in breast cancer. Cancer. 66: 848-852

Erner E (2005) Genome semantics, in silico multicellular systems and the central dogma. FEBS Letters. 579: 1779-1782

Gamaz M, Ameur S, Chaouche D, et al. (2004) A retrospective analysis to evaluate adjuvant chemotherapy after radical surgery on survival and disease recurrence in patients with stage I, II, IIA non-small cell lung cancer (NSCLC). J Clinical Oncology. 22: –

Gandey A (2006) Thermal ablation and radiotherapy boost lung cancer survival. J Vasc Interv Radiol. 17: 0-0

Ganz P, Desmond K, Leedham B, et al. (2002) Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J the National Cancer Institute. 94: 39-49

Girgis A, Adams J, Sibbritt D (2005) The use of complementary and alternative therapies by patients with cancer. Oncology Research. 15: 281-289

Gralla R, Thatcher N (2004) Quality-of-life assessment in advanced lung cancer: considerations for evaluation in patients receiving chemotherapy. Lung Cancer. 46: 41-17

Hand J, Machin D, Vernon C, et al. (1997) Analysis of thermal parameters obtained during phase III trials of hyperthermia as an adjunct to radiotherapy in the treatment of breast carcinoma. Int J Hyperthermia. 13: 343-364

Hanigan M, Devarajan P (2003) Cisplatin nephrotoxicity: molecular mechanisms. Cancer Therapy. 1: 47-61

Hashine K, Azuma K, Koizumi T, et al. (2005) Health-related qualit of life and treatment outcomes for men with prostate cancer treated by combined external-beam radiotherapy and hormone therapy. International J Clinical Oncology. 10: 45-50

Hayashi K, Iida T, Iwata M, et al. (1999) Multidisciplinary treatment with and without hyperthermia for ovarian carcinoma. Int J Clin Oncol. 4: 378-383

Herbert A (1981) Natural electrical RF oscillation from cells. J Bioenergetics and Biomembranes. 13: 149-169

Holt J (1986) The fundamental chemistry of life. Medical Hypotheses. 12: 359-367

Holt J (1997) A theoretical biochemical basis of cancer: confirmation by electromagnetic radiation. J Orthomolecular Medicine. 12: 149-163

Holt J (1996) Cancer therapy by immobilizing mitotic energy sources. J Orthomolecular Medicine. 11: 100-110

Holt J (1995) Some characteristics of the glutathione cycle revealed by ionising and non-ionising electromagnetic radiation. Medical Hypotheses. 45: 345-368

Holt J (1993) The glutathione cycle is the creative reaction of life and cancer. Cancer causes oncogenes and not vice versa. Medical Hypotheses. 40: 262-266

Holt J (1988) Microwaves are not hyperthermia. The Radiographer. 35: 151-162

Holt J (1983) Cancer, a disease of defective glucose metabolism. Medical Hypotheses. 10: 133-150

Holt J (2004) The energy system creating life and cancer from inanimate compounds. J Orthomolecular Medicine. 19: 141-161

Holt J (2004) The unique exponential growth of life is powered by anaerobic glycolysis. J Molecular Liquids. 114: 193-206

Holt J (2001) The metabolism of sulphur in relation to the biochemistry of cystine and cysteine: its fundamental importance in biology. A cyclic interchange between their mono- and di-sulphides is the unique reaction creating life and intelligence. Medical Hypotheses. 56: 658-676

Holt J, Nelson A (1985) Combined microwave therapy. The Medical J Australia. 142: 707-

Holt J, Stanford W (1986) The synergism between hyperthermia and ionising radiation. The British J Radiology. 59: 795-796

Holzner B, Kemmler G, Kopp M, et al (2001) Quality of life in breast cancer patients – not enough attention for long-term survivors?. Psychosomatics. 42: 117-123

Hotta K, Matsuo K, Ueoka H, et al. (2004) Role of adjuvant chemotherapy in patients with resected non-small-cell lung cancer: reappraisal with a meta-analysis of randomized controlled trials. J Clinical Oncology. 22: 3860-3867

Joines W, Jirtle R, Rafal D, et al. (1980) Microwave power absorption differences between normal and malignant tissue. Nat J Radiation Oncology Biol Phys. 6: 681-687

Joseph J, Al-Qaisieh B, Ash D, et al. (2004) Prostate-specific antigen relapse-free survival in patients with localized prostate cancer treated by brachytherapy. BJU International. 94: 1235-

Kapp D, Fessenden P, Samulski T, et al. (1988) Stanford University institutional report. Phase I evaluation of equipment for hyperthermia treatment of cancer. Int J Hyperthermia. 4: 75-115

Kekwick R, Pedersen K (Unknown year) CCCVIII Some physico-chemical characteristics of the yellow respiratory enzyme. . : 2201-2205

Kirson E, Gurvich Z, Schneiderman R, et al. (2004) Disruption of cancer cell replication by altering electric fields. Cancer Research. 64: 3288-3295

Kobayashi A, Yamamoto N, Kirschvink J (1997) Studies of inorganic crystals in biological tissue: magnetite in human tumor. J the Japan Society of Powder and Power Metallurgy. 44: 294-300

Koller M, Lorenz W, Wagner K, et al. (2000) Expectations and quality of life of cancer patients undergoing radiotherapy. J R Soc Med. 93: 621-628

Kruger R, Miller K, Reynolds H, et al. (2000) Breast cancer in vivo: contrast enhancement with thermoacousitc Ct at 434 MGz-feasibility study. Radiology. 216: 279-283

Langendijk J, Aaronson N, ten Velde G, et al. (2000) Pretreatment quality of life of inoperable non-small cell lung cancer patients referred for primary radiotherapy. Taylor & Francis. 39: 949-958

Li R, Wheeler T, Dai H, et al. (2004) High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy. American J Surgical Pathology. 28: 928-934

Lindholm C, Andreasson L, Knoos T, et al. (1990) Arterial rupture after microwave-induced hyperthermia and radiotherapy. Int J Hyperthermia. 6: 499-509

Mac Manus M, Matthews J, Wada M, et al. (2006) Unexpected long-term survival after low-dose palliative radiotherapy for nonsmall cell lung cancer. Cancer. 106: 1110-1116

Masunaga S, Hiraoka M, Takahashi M, et al. (1990) Clinical results of thermoradiotherapy for locally advanced and/or recurrent breast cancer – comparison of results with radiotherapy alone. Int J Hyperthermia. 6: 487-197

McCulloch M, See C, Shu X, et al. (2006) Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials. J Clinical Oncology. 24: 419-430

Melzack R (1975) The McGill pain questionnaire; major properties and scoring methods. Pain. 1: 277-299

Michaelson S (1980) Microwave biological effects: an overview. Proceedings of the IEEE. 68: 40-49

Nelson A, Holt J (1978) Combined microwave therapy. The Medical J Australia. : –

Newell S, Sanson-Fisher R (2000) Australian oncologist’s self-reported knowledge and attitudes about non-traditional therapies used by cancer patients. MJA. 172: 110-113

Nordin K, Berglund G, Terje I, et al. (1999) The mental adjustment to cancer scale – a psychometric analysis and the concept of coping. Psycho-oncology. 8: 250-259

Not Known (1976) The Tronado microwave machine: a further report. The Medical J Australia. 31st July: 156-157

Nowak A, Stockler M, Byrne M (2004) Assessing quality of life during chemotherapy for pleural mesothelioma: feasibility, validity, and results of using the European organization for research and treatment of cancer core quality of life questionnaire and lung cancer module. J Clinical Oncology. 22: 3172-3180

O’Brien M, Anderson H, Kaukel E, et al. (2004) SRL172 (killed Mycobacterium vaaccae) in addition to standard chemotherapy improves quality of life without affecting survival, in patients with advanced non-small-cell lung cancer: phase III results. Annals of Oncology. 15: 906-914

Osaro E, H.S.A. Aluyi (2004) Oxygen uptake kinetics of pseudomonas sp. Strain vb grown under limiting concentration of 2-methoxyethanol. African J biotechnology. 2: 353-354

Overgaard J, Gonzalez Gonzalez D, Hulshof M, et al. (1995) Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. The Lancet. 345: 540-543

Overgaard J, Gonzalez Gonzalez D, Hulshof M, et al. (1996) Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology. Int J Hyperthermia. 12: 3-20

PapandreouI, Krishna Cm Kaper F, et al. (2005) Anoxia is necessary for tumour cell toxicity caused by a low-oxygen environment. Cancer Research. 65: 3171-3178

Paul S, Simons J, Mabjeesh J (2004) HIF at the crossroads between ischemia and carcinogenesis. J Cellular Physiology. 200: 23-30

Perkins G, Slater E, Sanders G, et al. (2003) Serum tumour markers. American Family Physician. 68: 1075-1082

Perumal S, Shanthi P, Sachdanandam P (2005) Energy-modulating vitamins–a new combinatorial therapy prevents cancer cachexia in rat mammary carcinoma. Br J Nutr. 93: 901-909

Pienta K, Smith D (2005) Advances in prostate cancer chemotherapy: a new era begins. CA Cancer J Clin. 55: 300-318

Porter C, Kodama K, Gibbons R, et al. (2006) 25-year prostate cancer control and survival outcomes: a 40-year radical prostatectomy single institution series. J Urol. 176: 569-574

Potosky A, Davis W, Hoffman R, et al. (2004) Five-year outcomes after prostateectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J the National Cancer Institute. 96: 1358-1367

Rosser C, Kamat A, Wang X, et al. (2006) Biochemical disease-free survival in men younger than 60 years with prostate cancer treated with radical prostatectomy. Urology. 67: 769-773

Ryan C, Zelefsky M, Heller G, et al. (2004) Five-year outcomes after neoadjuvant chemotherapy and conformal radiotherapy in patients with high-risk localized prostate cancer. Urology. 64: –

Sandler A (2003) Chemotherapy for small cell lung cancer. Semin Oncol. 30: 9-25

Segelov E (2006) The emperor’s new clothes – can chemotherapy survive?. Australian Presceiber. 29: 2-3

Selak M, Armour S, MacKenzie E, et al. (2005) Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-a prolyl dyroxylase. Cancer Cell. 7: 77-85

Senior A, McGowan S, Hilf R (1975) A comparative study on inner membrane enzymes and transport systems in mitochondria from R3230AC mammary tumour and normal rat mammary gland. Cancer Research. 35: 2061-2067

Sharpless N, DePinho A (2002) Good cop/bad cop. Cell. 110: 9-12

Shchepotin I, Evans S, Chorny V, et al. (1994) Intensive peroperative radiotherapy with local hyperthermia for the treatment of gastric carcinoma. Surgical Oncology. 3: 37-44

Silvestris N, Leone B, Numico G, et al. (2005) Present status and perspectives in the treatment of hormone refractory prostate cancer. Oncology . 69: 273-282

Simonnet H, Demont J, Pfeiffer K, et al. (2003) Mitochondial comples I is deficient in renal oncocytomas. Carcinogenesis. 24: 1461-1466

Sloan J (2003) Quality-of-life meta-analysis: why treat it differently?. J Clinical Oncology. 21: 1422-1423

Streckert J (2003) Technical equipment requirements in investigations of radiofrequency effects in biological systems. Forschungsgemeinschaft Funk. 18: 1-19

Trask P (2004) Quality of life and emotional distress in advianced prostate cancer survivors undergoing chemotherapy. Health and Qualityo f Life Outcomes . 2: –

Trotter J, Edis A, Blackwell J, et al. (1996) Adjuvant VHF therapy in locally recurrent and primary unresectable rectal cancer. Australasian Radiology. 40: 298-305

van der Zee J, Gonzalez D, van Rhoon G, et al. (2000) Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. The Lancet. 355: 119-1125

Van Vulpen M, De Leeuw J, Van Gellekom P, et al. (2003) A prospective quality of life study in patients with locally advanced prostate cancer, treated with radiotherapy with or without regional or interstitial hyperthermia. Int J Hyperthermia. 19: 402-413

Van Waveren C, Sun Y, Cheung H, et al (2006) Oxidative phosphorylation dysfunction modulates expression of extracellular matrix – remodeling genes and invasion. Carcinogenesis. 27: 409-418

Vulpen M, de Leeuw A, Raaymakers, et al (2004) Radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate cancer: preliminary results. BJU International. 93: 36-

Willner J, Viktor W, Jachmann M, et al. (2004) Is survival following post-operative radiotherapy in pN1-non-small cell lung cancer reduced? Results of a multivariate analysis. Oncology Reports. 12: 647-653

Winquist E (2006) Chemotherapy for non-hormone refractory prostate cancer. Can J Urol. 13: 67-70

Wissniowski T, Hansler J, Neureiter D, et al. (2003) Activation of tumor-specific t lymphocytes by radio-frequency ablation of the VX2 heptoma in rabbits. Cancer Research. 63: 6496-6500

Yang Z, Wu X, Ou Y, et al. (2004) Effect of TCM combined with chemotherapy on immune function and quality of life of patients with non-small cell lung cancer in stage III-IV. Chinese J Integrative Medicine. 10: 181-186

Zeng F, Zimmerman S (1997) Dendrimers in supramolecular chemistry: from molecular recognition to self-assembly. Chem Rev. 97: 1681-1712

Zhu Z, Jiang W, McGinley J, et al. (2005) 2-deoxyglucose as an energy restriction mimetic agent: effects on mammary carcinogenesis and on mammary tumor cell growth in vitro. Cancer Research. 65: 7023-7030